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OBJECTIVES We sought to compare patient outcomes for coronary stent placement and balloon
angioplasty.
BACKGROUND Since 1994, the number of patients treated only with balloon angioplasty has decreased
nationally, whereas the use of coronary stents as an alternative has grown tremendously. The
objectives of this study were to compare short- and long-term survival and subsequent
revascularization rates for patients undergoing single-vessel balloon angioplasty and coronary
stent placement.
METHODS New York’s Coronary Angioplasty Registry was used to identify New York patients
undergoing either balloon angioplasty or stent placement between July 1, 1994, and
December 31, 1996. Statistical models were used to compare risk-adjusted short- and
long-term survival and subsequent coronary artery bypass graft surgery (CABG) and
percutaneous coronary interventions (PCIs).
RESULTS No significant differences were found in adjusted in-patient mortality, but patients who had
balloon angioplasty were, on average, 1.36 times more likely to have died at any time during
the two-year period after the index procedure (p 5 0.003). The adjusted in-patient CABG
rate was significantly higher for balloon angioplasty (2.72% vs. 1.66%, p , 0.0001), and the
adjusted two-year CABG rate was also significantly higher for balloon angioplasty (10.81%
vs. 7.25%, p , 0.001). The adjusted two-year rate for subsequent PCIs was also significantly
higher for balloon angioplasty (19.6% vs. 14.3%, p , 0.0001). Although measures were taken
to eliminate or minimize the effect of selection bias, it should be noted that patients with
stents were healthier at hospital admission than patients who had balloon angioplasty.
CONCLUSIONS Stent placement is associated with significantly lower risk-adjusted long-term mortality,
CABG and subsequent PCI rates, as compared with balloon angioplasty. (J Am Coll Cardiol
2000;36:395–403) © 2000 by the American College of Cardiology
Since its introduction by Gruentzig in 1977, percutaneous
transluminal coronary angioplasty (PTCA) has experienced
extraordinary growth, with nearly 500,000 procedures per-
formed in the United States in 1997 (1). Much of this
growth is attributable to the technological advances in
equipment and catheter design that have taken place during
the past two decades to make the procedure both safe and
successful, at least in the short term. The main limitation of
the procedure has been restenosis, a renarrowing of the
arterial lesion at the original site of the dilation. Restenosis
occurs in ;35% of patients undergoing PTCA within six
months of the procedure. With the demonstration in 1994
that coronary stents could be used not only to “bail out”
from the life-threatening complications after failed balloon
angioplasty, but also to “back up” or improve suboptimal
balloon angioplasty results, the stent has been enthusiasti-
cally embraced by the interventional community. By 1996,
stents were employed in more than one-half of all percuta-
neous interventions in both the United States and Europe
(2,3).
There is evidence that coronary stenting has been more
successful than balloon angioplasty in improving short- and
long-term angiographic outcomes, reducing the rate of
restenosis, preventing abrupt vessel closure and decreasing
the incidence of target vessel revascularization. However, no
study to date has had a large enough group to adequately
assess the separate impacts of stenting on mortality and the
need for coronary artery bypass graft surgery (CABG)
during the same hospital stay, as compared with balloon
angioplasty alone. The purpose of this study was to use a
very large observational data base to compare short- and
long-term outcomes of patients treated with balloon angio-
plasty alone with the outcomes of those also receiving
intracoronary stents.
METHODS
Data bases. The primary data base used for the study is
New York State’s Coronary Angioplasty Reporting System
(CARS), which was established in 1991 by the New York
State Department of Health (the Department) and its
Cardiac Advisory Committee (CAC). The cardiac cathe-
terization laboratories in the 33 hospitals in which angio-
plasty is performed in New York are responsible for coding
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the CARS data form to capture the relevant information.
To assure reporting accuracy, comprehensive audits of
approximately one-half of the hospitals in the registry are
conducted on behalf of the Department each year, and
several hospitals have been asked to recode all or part of
their data as a result of the audits.
For each patient undergoing a percutaneous coronary
interventions (PCI) in New York State, CARS contains
demographic information; clinical risk factors; patient, op-
erator and hospital identifiers; complications; and discharge
status from the hospital. CARS has been used to identify
significant risk factors and volume–outcome relations for
PCIs (4,5), generate public reports that provide risk-
adjusted mortality rates for PCI in New York State hospitals
in which the procedure is performed (6) and compare
long-term outcomes for angioplasty and CABG (7).
Another data base needed for the study was New York’s
vital statistics death file, which identifies all residents of the
state who die each year. Because CARS and the death file
contain patient social security numbers, deaths subsequent
to discharge after the index hospital period were able to be
tracked. Subsequent CABGs and PCIs for each patient in
New York State were also tracked using CARS and a
similar New York State registry for cardiac surgery—the
Cardiac Surgery Reporting System (CSRS).
Study group and end points. The total number of patients
undergoing balloon angioplasty with or without adjunctive
stent placement from July 1, 1994 to December 31, 1996 in
the 33 hospitals certified to perform the procedures was
38,468. This group was first limited by excluding non–New
York State residents (n 5 1,626). Further exclusions were
patients who had a previous revascularization (n 5 4,745),
had the left main coronary artery attempted (n 5 91) or had
more than one lesion attempted (n 5 12,149). Patients who
underwent other PCIs (e.g., atherectomy, laser angioplasty)
in addition to balloon angioplasty or stent placement (n 5
5,752) were also excluded. Some patients were excluded for
more than one reason. Patients with more than one lesion
attempted were not considered because it was impossible to
determine if patients who were coded as stent placement/
balloon angioplasty had stent placements on all lesions
attempted or if balloon angioplasty was the only interven-
tion attempted on some lesions. This approach led to the
identification of 19,792 patients, 12,595 of whom under-
went balloon angioplasty and 7,197 of whom underwent
stent placements.
Study end points include short-term (in-patient) mortal-
ity and CABG; and long-term (two-year) mortality, CABG
and subsequent PCIs.
Data analysis. For each of the two procedures, the preva-
lence associated with each available determinant of mortal-
ity was calculated. These variables included the number of
vessels with disease (with at least 70% stenosis) and lesion
type attempted; patient age, gender, race and ethnicity; a
variety of comorbidities; and measures of the patient’s
hemodynamic state and ventricular function. All variables,
including age and ejection fraction, were treated as categoric
variables. Chi-square tests were used to identify significant
differences in prevalence rates between the procedures.
Before the development of multivariate statistical models
for short- and long-term mortality, subsequent CABG and
subsequent PCI, treatment selection bias was controlled for
in each model by obtaining a propensity score, which was
the probability that a patient would undergo balloon angio-
plasty rather than stent placement. The propensity score for
each patient was obtained by fitting a logistic regression
model with a binary dependent variable representing bal-
loon angioplasty. Independent variables consisted of all
patient risk factors contained in CARS. The adequacy of
the propensity score, ranging from 0 to 1, was confirmed by
subdividing it into quintiles and testing for differences in the
frequency of model covariates between patients who under-
went balloon angioplasty and those who underwent stent
placement. The propensity score was then used as an
independent variable to adjust for treatment selection bias in
subsequent statistical models with patient outcomes as
dependent variables (8–10).
The difference in the observed in-patient mortality rates
for the two procedures was tested using the chi-square test.
To compare risk-adjusted in-patient mortality rates for the
two interventions, a stepwise logistic regression model was
developed using the LOGISTIC procedure in SAS, version
6.12 (SAS Institute, Cary, North Carolina). Discharge
status from the hospital after the procedure, with in-hospital
mortality coded as “1,” was used as the binary dependent
variable. The propensity score was used in the model to
control for selection bias, and candidates for other indepen-
dent variables included all the demographic and clinical
variables available in CARS. After the logistic regression
model was developed, risk-adjusted mortality rates (ob-
served/expected mortality rate ratios multiplied by the
statewide mortality rate) for the two interventions were
tested for significant differences. The same analysis strategy
was then repeated using subsequent in-patient CABG as
the dependent variables.
To check the results, a second approach to the propensity
score method was used. The propensity score was subdi-
vided into five equal ranges, and differences in outcome rates
for patients who had balloon angioplasty or stent placement
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAC 5 Cardiac Advisory Committee
CARS 5 Coronary Angioplasty Reporting System
COPD 5 chronic obstructive pulmonary disease
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were tested using the chi-square test. In both cases, the
same conclusion was reached.
Two-year survival was examined for each intervention
while controlling for differences in patient severity of illness,
using the stepwise Cox proportional hazards model and the
SAS procedure, PHREG (version 6.12). The intervention
type was coded as a binary independent variable. Candidate
variables in the model included age, gender, ethnicity, race,
ejection fraction, previous myocardial infarction (MI), num-
ber of vessels with disease, lesion type attempted and
Table 1. Risk Factors of Patients Undergoing Coronary Angioplasty or Stent Placement on One Lesion for the First Time in New
York State, July 1994–December 1996
Risk Factor
% Balloon Angioplasty Patients
With Risk Factor
(n 5 12,595)
% Stent Placement Patients
With Risk Factor
(n 5 7,197)
p
Value
Age (yrs) , 0.001
,55 30.2 33.0
55–64 27.0 28.9
65–74 28.5 26.5
75–84 13.2 10.8
$85 1.1 0.9
Female gender 34.7 31.3 , 0.001
Hispanic ethnicity 5.7 5.3 0.200
Race 0.003
White 89.4 90.9
Black 6.2 5.2
Other 4.4 3.9
Ejection fraction (%) 0.002
,20 0.6 0.3
20–29 2.1 1.8
30–39 6.0 5.5
401 77.9 80.1
Missing 13.5 12.3
Previous MI , 0.001
,6 h 8.1 5.4
6–23 h 4.1 2.5
1–7 days 20.4 21.0
$8 days 22.5 19.1
None 45.0 52.1
Stroke 2.6 1.7 , 0.001
Carotid/cerebrovascular disease 2.5 1.8 0.002
Aortoiliac disease 2.9 1.9 , 0.001
Femoral/popliteal disease 3.4 2.5 , 0.001
Hemodynamically unstable 2.3 1.1 , 0.001
Shock 1.1 0.4 , 0.001
ECG evidence of LVH 5.6 4.9 0.038
Malignant ventricular arrhythmia 2.6 2.3 0.116
Chronic obstructive pulmonary disease 4.6 4.1 0.107
CHF , 0.001
This admission 5.5 4.2
Before this admission 2.4 2.3
None 92.2 93.5
Diabetes requiring medicine 18.3 14.5 , 0.001
Renal failure 0.054
With dialysis 0.6 0.5
Creatinine .2.5 mg/dl 0.9 0.6
No renal failure 98.5 98.9
Left main coronary artery disease ($50%) 0.5 0.5 1.000
No. of vessels with disease ($70%) , 0.001
0 1.0 0.8
1 73.3 78.2
2 21.3 18.0
3 4.4 3.0
Lesion type attempted , 0.001
C 22.3 21.2
B 64.5 68.7
A 13.0 10.1
CHF 5 congestive heart failure; ECG 5 electrocardiographic; LVH 5 left ventricular hypertrophy; MI 5 myocardial infarction.
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numerous comorbidities (Table 1). Ninety-five percent
confidence intervals for the hazard ratios were calculated to
test for significant differences in survival between balloon
angioplasty and stent placement. This was done for all
patients and for eight selected subsets of patients.
To measure survival differences between balloon angio-
plasty and stent placement in percentages rather than in
relative terms for each anatomic subgroup, a Cox propor-
tional hazards model for the subgroup was used to construct
adjusted Kaplan-Meier survival curves for balloon angio-
plasty and stent placement, where treatment was used as a
stratification factor instead of a model covariate. A chi-
square test was used to test for differences in two-year
survival among patients undergoing the two procedures.
The long-term analyses just described were then repeated
with subsequent CABG and subsequent PCI used as the
dependent variables in lieu of mortality, with deaths during
the two-year period being treated as censored data.
RESULTS
Table 1 presents the frequency with which each available
risk factor was present among patients undergoing balloon
angioplasty and stent placement. As noted in Table 1, there
were statistically significant differences in the prevalences of
all patient risk factors, except for Hispanic ethnicity, ma-
lignant ventricular arrhythmia, chronic obstructive pulmo-
nary disease (COPD), renal failure and left main coronary
artery disease between the balloon angioplasty cohort and
stent placement cohort. In general, stents were deployed in
younger, healthier patients. In fact, for 17 of the 21 risk
factors that were examined, patients who had balloon
angioplasty had significantly higher prevalence rates.
Table 2 presents the unadjusted and adjusted in-patient
mortality rates and the same admission CABG rates for
patients undergoing balloon angioplasty and stent place-
ment. Although the unadjusted (observed) in-patient mor-
tality rates (1.01% for balloon angioplasty and 0.49% for
stent placement) were significantly different (p , 0.001),
the respective risk-adjusted rates (0.85% and 0.71%) were
not statistically different (p 5 0.50).
With respect to CABG in the same admission after the
index angioplasty procedure, the unadjusted rates (2.95% for
patients undergoing balloon angioplasty and 1.42% for
patients undergoing stent placement) were significantly
different (p , 0.001). After risk adjustment, the respective
rates of 2.72% and 1.66% remained statistically significant
(p , 0.001).
Figure 1 presents the logarithms of the adjusted mortality
hazard ratios for the entire two-year period for balloon
angioplasty/stent placement for all patients in the study and
for eight subgroups of patients. The logarithm of the hazard
ratio for balloon angioplasty/stent placement is 0.307,
which translates (by exponentiation) into a hazard ratio of
1.36 (p 5 0.003). Thus, after adjusting for differences in
patient risk factors, patients undergoing balloon angioplasty
were 1.36 times more likely to be dead at any point in time,
as compared with patients undergoing stent placement.
As demonstrated in Figure 1, three of the eight subgroups
that were examined (non–left anterior descending coronary
artery [LAD] attempted, diabetes and MI within 24 h
before the procedure) had a statistically significant hazard
ratio. However, patients undergoing balloon angioplasty
were significantly more likely to be dead at a fixed time for
all eight groups.
Figure 2 contains the two-year adjusted mortality curve
for balloon angioplasty and stent placement for all patients.
As indicated, the survival advantage of stent placement was
present throughout the two-year period. The cumulative
adjusted mortality rates for stent placement for half-year
increments during the course of two years were 1.7%, 2.5%,
3.0% and 3.8%. The comparable adjusted mortality rates for
balloon angioplasty were 2.4%, 3.2%, 4.0% and 4.8%. The
adjusted mortality difference at two years was statistically
significant (p , 0.001), and differences at other times were
at least marginally significant (with respective p values of
0.02, 0.08 and 0.01). Recalling that the adjusted in-patient
mortality rate was 0.85% for balloon angioplasty, we can see
that all six-month percent increases were 0.8%, except for
the period between hospital discharge and six months.
During that period, the cumulative mortality rate for bal-
loon angioplasty rose from 0.85% to 2.4%.
Figure 3 presents the logarithms of the adjusted balloon
angioplasty/stent placement hazard ratios for subsequent
CABG. As depicted in Figure 3, the logarithm of the
CABG hazard ratio for balloon angioplasty/stent placement
is 0.515, which when exponentiated, translates into a
statistically significant 1.67 hazard ratio.
Of the same eight patient subgroups investigated in
Figure 1, six (single-vessel disease, two- or three-vessel
disease, all patients who did not have their LAD attempted,
Table 2. Unadjusted and Adjusted Short-term Outcomes for Balloon Angioplasty and Stent Placement
Outcome
Balloon
Angioplasty
Stent
Placement
p
Value
Unadjusted in-patient mortality (%) 1.01 0.49 , 0.001
Adjusted in-patient mortality (%)* 0.85 0.71 0.50
Unadjusted rate of CABG in same admission (%) 2.95 1.42 , 0.001
Adjusted rate of CABG in same admission (%)† 2.72 1.66 , 0.001
*Adjusted using propensity score, age, myocardial infarction within 24 h before the procedure, hemodynamic instability, shock, malignant ventricular arrhythmia, diabetes and
renal failure. †Adjusted using propensity score, two- or three-vessel disease, lesion type C, carotid disease, hemodynamic instability, shock, chronic obstructive pulmonary disease,
and Hispanic ethnicity.
CABG 5 coronary artery bypass graft surgery.
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all patients with no or single-vessel disease who did not have
their LAD attempted, all patients who had their proximal
LAD attempted and all patients with two- or three-vessel
disease who had their proximal LAD attempted) had
significant hazard ratios for subsequent CABG. All eight
subgroups had hazard ratios .1.
In addition to mortality rates, Figure 2 demonstrates the
two-year curves that represent CABG for patients with
index procedures of balloon angioplasty and stent place-
ment. As indicated, patients undergoing stent placement
were less likely to undergo subsequent CABG throughout
the two-year period. The cumulative adjusted CABG rates
for patients undergoing stent placement for half-year incre-
ments during the course of two years were 4.3%, 5.8%, 6.4%
and 7.2%. The comparable adjusted CABG rates for pa-
tients undergoing balloon angioplasty were 7.3%, 9.1%,
10.0% and 10.8%. The CABG rates at two years were
statistically different (p , 0.001). An examination of the
two curves indicates that the two rates were quite different
shortly after the procedure was performed, and that this
differential remained about the same throughout the two-
year period. This suggests that the benefit of stenting is a
result of its preventive effect on acute or subacute vessel
closure.
Figure 4 presents the logarithms of the adjusted balloon
angioplasty/stent placement hazard ratios for subsequent
PCI. The logarithm of the PCI hazard ratio is 0.391, which
yields a statistically significant 1.48 hazard ratio (p ,
0.0001). Also, five of the eight patient subgroups had
significant hazard ratios for subsequent PCI.
Figure 2 also contains the two-year curves that represent
subsequent PCI for patients with index procedures of
balloon angioplasty and stent placement. Patients undergo-
ing stent placement were less likely to undergo subsequent
PCI throughout the two-year period. The subsequent PCI
rates at two years (14.3% for stent placement and 19.6% for
balloon angioplasty) were statistically different (p , 0.001).
An inspection of the two curves indicates that the gap
between the two procedures widened until about six months
subsequent to the performance of the procedure, after which
time the gap remained constant. This suggests that higher
periprocedural restenosis rates among patients who had
balloon angioplasty is the primary determinant of the
difference.
DISCUSSION
Other studies. Several studies have demonstrated the su-
periority of coronary stenting as compared with balloon
Figure 1. Ninety-five percent confidence intervals for the adjusted hazard ratio of balloon angioplasty/stent placement for patient death within a two-year
period (for all patients and for eight subgroups of patients).
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angioplasty. For example, Fischman et al. (11) showed that
patients who underwent stenting had significantly larger
lumen diameters immediately after the procedure and six
months later, a significantly lower rate of restenosis after six
months (31.6% vs. 42.1% for balloon angioplasty) and a
significantly lower rate of revascularization of the target
lesion within six months (10.2% vs. 15.4%).
Serruys et al. (12) of the BElgian NEtherlands STENT
(BENESTENT) study group found that patients undergo-
ing stenting had a significantly reduced need for a second
coronary angioplasty during the seven months subsequent to
the index procedure (relative risk 0.58, p 5 0.005) and a
significantly lower rate of restenosis (22% vs. 32%, p 5
0.02), but more peripheral vascular complications (13.5% vs.
3.1%, p , 0.001). In another randomized clinical trial
conducted by the BENESTENT Study Group, Macaya et
al. (13) found that the need for repeat angioplasty was
significantly lower in the stent group than in the balloon
angioplasty group (10% vs. 21%, p 5 0.001).
Several other studies reported the superiority of outcomes
in patients undergoing stent placement rather than balloon
angioplasty for selected groups of patients, including those
with small coronary arteries (14), acute MI (15), obstructed
coronary artery bypass grafts (16) and restenosis after
balloon angioplasty (17). Other studies devoted entirely to
stent implantation for selected groups of patients reported
encouraging outcomes for patients with an acute MI (18),
for multiple stent implantation in single coronary arteries
(19), for stenoses of the left main coronary artery in patients
who cannot undergo CABG (20), for stenoses in saphenous
vein grafts (21,22) and for total occlusions that have been
recanalized with PTCA or laser angioplasty (23,24).
Summary of results. This study found that risk-adjusted
in-patient mortality rates for balloon angioplasty and stent
placement were not statistically different. However, the
risk-adjusted in-patient CABG rate for patients undergoing
balloon angioplasty was significantly higher (2.72% vs.
1.66%, p , 0.001). Also, patients undergoing balloon
angioplasty were, on average, significantly more likely (rel-
ative risk 1.36, p 5 0.003) to die at any point during the
two-year period after the index procedure than were patients
undergoing stent placement, after adjusting for differences
in preprocedural severity of illness.
The adjusted rate of subsequent CABG after two years
was significantly lower for patients undergoing stent place-
ment (7.2%) than for patients undergoing balloon angio-
plasty (10.8%), and the adjusted rate of subsequent PCI
after two years was also lower after stent placement (14.3%
vs. 19.6%).
The results reported here should be of considerable
interest, although they are not derived from a clinical trial.
First, except for deliberate exclusions, the data represent
consecutive patients undergoing balloon angioplasty and
stent placement in New York for a two-year period, and as
such, are more indicative of the full range of treatment in
the “real world” where these two procedures are employed.
Figure 2. Adjusted Kaplan-Meier curves for mortality, subsequent CABG and subsequent PCI for balloon angioplasty versus stent placement.
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Also, because the volume of each type of procedure was so
large, the findings enable us to judge the generalizability of
the randomized clinical trials that were conducted earlier
and to test for significant differences in mortality and
subsequent CABG separately with adequate statistical
power.
Caveats. There are some caveats that are important to
note. First, the study is not a randomized clinical trial.
This means that there could have been a selection bias
such that we did not adequately control for some variable
that increased the probability of undergoing balloon
angioplasty and the probability of short- and long-term
adverse outcomes. In fact, it appears as if stent place-
ments were used cautiously from 1994 through 1996, in
keeping with a “learning period” approach to their use.
Of 21 of the variables used as candidates in the risk-
adjustment process, 17 (81%) had significant prevalence
differences that increased the risk of balloon angioplasty
intervention versus stent intervention. Consequently, the
two patient groups were quite different with respect to
preprocedural risk.
We used a propensity score to control for treatment
selection bias, in addition to using multivariate statistical
models to control for differences in the prevalence of
significant risk factors. The propensity score method con-
trols for selection bias more extensively than any method
previously used to compare outcomes for stent placement
and balloon angioplasty. Nevertheless, the propensity score
is ideally comprised of all factors that are predictive of
treatment selection, and we did not have access to important
determinants such as vessel size. Also, the study took place
during a time when the use of coronary stenting changed
dramatically, such that there was no steady state in the use
of stents. Consequently, the propensity to use stents in early
1994 was much different than the propensity to use them in
late 1996, even among patients who had identical risk
factors and propensity factors in the two periods.
Another caveat is that the study was confined to patients
who had a single lesion attempted, because it was impossible
to determine whether patients with multiple lesions at-
tempted underwent a combination of balloon angioplasty
and stent placement. However, 71% of the patients who
underwent one of the two procedures did have a single
lesion attempted, so the results should be at least represen-
tative of the majority of patients.
In addition, there is a possibility that the results could be
biased as a result of incomplete follow-up of postdischarge
deaths. The national death file was unusable because patient
Figure 3. Ninety-five percent confidence intervals for the adjusted hazard ratio of balloon angioplasty/stent placement for CABG within a two-year period
(for all patients and for eight subgroups of patients).
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names were not available, so New York State vital statistics
data were used to identify patients who died after discharge.
Because of this, the study was limited to patients residing in
New York at the time the procedure was performed. We
were not able to capture deaths or subsequent revascular-
izations for patients who moved to another state subsequent
to discharge, but results from a similar study comparing
outcomes of CABG and PCI in New York indicate that
very few deaths are missed because of patients moving out of
state (7).
We look forward to new studies that compare balloon
angioplasty and stent placement for large patient popula-
tions and to studies that compare stent placement with
CABG as a function of the number of vessels with disease
and the location of disease.
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